Susquehanna International Group
VVOS icon

Susquehanna International Group’s Vivos Therapeutics VVOS Stock Holding History

Susquehanna International Group’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58K Buy
+10,075
New +$7.9K ﹤0.01% 13196
2022
Q4 		– Sell
-1,659
Closed -$27K – 13802
2022
Q3 		$27K Buy
+1,659
New +$50.5K ﹤0.01% 12494
2022
Q2 		– Sell
-950
Closed -$64K – 14051
2022
Q1 		$64K Sell
950
-1,703
-64% -$111K ﹤0.01% 12190
2021
Q4 		$150K Buy
2,653
+457
+21% +$36.8K ﹤0.01% 11792
2021
Q3 		$222K Buy
+2,196
New +$231K ﹤0.01% 11257

Other funds holding VVOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Susquehanna International Group's VVOS Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Vivos Therapeutics (VVOS) in Q2 2026: 10,075 shares worth $4.58K. The stake represents ﹤0.01% of the portfolio and ranks #13196 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in VVOS as recently as Q3 2022.

Susquehanna International Group first reported a position in VVOS in Q3 2021 and has held it in 5 quarters since. The position peaked at $222K in Q3 2021. 23 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

  • Susquehanna International Group held 10,075 shares of Vivos Therapeutics worth $4.58K as of Q2 2026.
  • Vivos Therapeutics was a new Susquehanna International Group position in Q2 2026.
  • Vivos Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13196 holding.
  • Susquehanna International Group first reported a position in Vivos Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • Susquehanna International Group's Vivos Therapeutics position peaked at $222K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.